BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Levi & Korsinsky, LLP Announces Class Action Against Questcor Pharmaceuticals, Inc. (Headquarters) (QSC) (QCOR) and Investigation of Metropolitan Health Networks, Inc.(MDF), KBW Inc. (KBW) and Sprint Nextel Corporation (S)


11/8/2012 10:12:12 AM

NEW YORK, Nov. 7, 2012 /PRNewswire/ --

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)

Questcor Pharmaceuticals, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who acquired Questcor Pharmaceuticals, Inc. (NasdaqGS: QCOR) securities between April 26, 2011 and September 21, 2012.

For more information, click here: http://zlk.9nl.com/questcor-pharmaceuticals-qcor. You have until November 26, 2012to request that the Court appoint you as lead plaintiff.

Metropolitan Health Networks, Inc.
Levi & Korsinsky is investigating the Board of Directors of Metropolitan Health Networks, Inc. (NYSE: MDF) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Humana Inc. (NYSE: HUM) for $11.25 per share. At least one analyst set a price target for Metropolitan stock at $13.00 per share.

Click here to learn more about the investigation: http://zlk.9nl.com/metropolitan-health-networks-mdf, or call: 877-363-5972.

KBW Inc.
Levi & Korsinsky is investigating the Board of Directors of KBW Inc. (NYSE: KBW) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Stifel Financial.

Click here to learn more about the investigation: http://zlk.9nl.com/kbw-kbw, or call: 877-363-5972.

Sprint Nextel Corporation
Levi & Korsinsky is investigating the Board of Directors of Sprint Nextel Corporation (NYSE: S) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of a 70% stake in the Company to Softbank Corp. for $7.30 per share.

Click here to learn more about the investigation: http://zlk.9nl.com/sprint-nextel-s, or call: 877-363-5972.

Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->